Finance

Beta
Lists
4538:TYO
Fuso Pharmaceutical Industries Ltd
¥2,064.00
-0.10%
(-2.00) 1D
Jun 25, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4538...
Open
¥2,087
High
¥2,087
Low
¥2,060
Mkt. cap
19.51B
Avg. vol.
25.54K
Volume
12.20K
Dividend
4.36%
Quarterly dividend
¥22
Ex-dividend date
Mar 30, 2026
P/E ratio
8.76
52-wk high
¥2,530
52-wk low
¥1,990
EPS
¥236
Shares outstanding
8.78M
No. of employees
1K
Open
¥2,087
High
¥2,087
Low
¥2,060
Mkt. cap
19.51B
Avg. vol.
25.54K
Volume
12.20K
Dividend
4.36%
Quarterly dividend
¥22
Ex-dividend date
Mar 30, 2026
P/E ratio
8.76
52-wk high
¥2,530
52-wk low
¥1,990
EPS
¥236
Shares outstanding
8.78M
No. of employees
1K
News stories
From sources across the web
About Fuso Pharmaceutical Industries Ltd
CEO-
Employees1.37K
FoundedMar 25, 1937
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.50B
15.73B
17.04B
14.04B
Cost of goods sold
11.42B
11.70B
12.62B
10.57B
Cost of revenue
11.42B
11.70B
12.62B
10.57B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.48B
3.38B
3.30B
3.20B
Operating expense
3.48B
3.38B
3.30B
3.20B
Total operating expenses
14.91B
15.08B
15.91B
13.77B
Operating income
597.00M
650.00M
1.12B
272.00M
Other non operating income
-18.00M
-110.00M
-24.00M
-40.00M
EBT including unusual items
646.00M
456.00M
1.20B
132.00M
EBT excluding unusual items
569.00M
478.00M
1.08B
131.00M
Income tax expense
184.00M
87.00M
350.00M
-195.00M
Effective tax rate
28.48%
19.08%
29.09%
-147.73%
Other operating expenses
-
-
-
-
Net income
462.00M
369.00M
853.00M
327.00M
Net profit margin
2.98%
2.35%
5.01%
2.33%
Earnings per share
-
-
-
-
Interest and investment income
60.00M
14.00M
67.00M
1.00M
Interest expense
-70.00M
-76.00M
-80.00M
-102.00M
Net interest expenses
-10.00M
-62.00M
-13.00M
-101.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
1.30B
-
926.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of 4538
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more